Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
An update from OptiBiotix Health ( (GB:OPTI) ) is now available.
OptiBiotix Health plc has signed a distribution agreement with a prominent weight management company to provide SlimBiome® and WellBiome® products under the distributor’s branding. This partnership aims to leverage the growing interest in non-drug alternatives for weight management, positioning OptiBiotix to integrate its science-backed ingredients into established brands. The agreement is expected to enhance OptiBiotix’s market presence and open new opportunities in the European market.
More about OptiBiotix Health
OptiBiotix Health plc, established in March 2012, is a life sciences company focused on developing compounds that modify the human microbiome to prevent and manage diseases and promote wellness. The company collaborates with international food and healthcare supplement companies to incorporate its microbiome modulators into various food products and drinks. OptiBiotix’s primary areas of focus include obesity, cardiovascular health, and diabetes.
Average Trading Volume: 346,232
Technical Sentiment Signal: Sell
Current Market Cap: £13.43M
Find detailed analytics on OPTI stock on TipRanks’ Stock Analysis page.